Cost Effectiveness of Respiratory Syncytial Virus Prophylaxis: A Critical and Systematic Review

Author： PrescottJr William A.   Doloresco Fred   Brown Jack   Paladino Joseph A.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.28, Iss.4, 2010-04, pp. : 279-293

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost Effectiveness of Palivizumab for Respiratory Syncytial Virus Prophylaxis in High-Risk Children: A UK Analysis

By Nuijten Mark J.C.   Wittenberg Wolfgang   Lebmeier Maximilian  

PharmacoEconomics, Vol. 25, Iss. 1, 2007-01 ,pp. : 55-71

Adis International

Access to resources Recommend Favorite

Palivizumab: A Review of its Use as Prophylaxis for Serious Respiratory Syncytial Virus Infection

By Fenton Caroline   Scott Lesley J.   Plosker Greg L.  

Pediatric Drugs, Vol. 6, Iss. 3, 2004-01 ,pp. : 177-197

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Pharmacogenomics: A Critical and Systematic Review

By Wong William B.   Carlson Josh J.   Thariani Rahber   Veenstra David L.  

PharmacoEconomics, Vol. 28, Iss. 11, 2010-11 ,pp. : 1001-1013

Adis International

Access to resources Recommend Favorite

Management of Anaemia: A Critical and Systematic Review of the Cost Effectiveness of Erythropoiesis-Stimulating Agents

By Mei Sheng Duh  

PharmacoEconomics, Vol. 26, Iss. 2, 2008-01 ,pp. : 99-120

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Therapeutic Interventions in Ankylosing Spondylitis: A Critical and Systematic Review

By Gaujoux-Viala Cécile   Fautrel Bruno  

PharmacoEconomics, Vol. 30, Iss. 12, 2012-12 ,pp. : 1145-1156

Adis International

Access to resources Recommend Favorite